Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Chihara

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Endocrine Journal|January 23, 2013
Efficacy, safety, and pharmacokinetics of sustained-release lanreotide (lanreotide Autogel) in Japanese patients with acromegaly or pituitary gigantismAkira Shimatsu, Akira Teramoto, Naomi Hizuka, et al.
JCEM Case Reports|May 20, 2026
Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenomaMaki Kanzawa, Takeshi Maeda, Yoshio Ohta, et al.
The Journal of Biological Chemistry|November 26, 2004
Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunDJunko Naito, Hiroshi Kaji, Hideaki Sowa, et al.
The Journal of Endocrinology|April 9, 2005
Dexamethasone suppresses Smad3 pathway in osteoblastic cellsMei-Fway Iu, Hiroshi Kaji, Hideaki Sowa, et al.
The Journal of Biological Chemistry|October 1, 2003
Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblastsHideaki Sowa, Hiroshi Kaji, Mei Fway Iu, et al.
Journal of Bone and Mineral Metabolism|November 2, 2005
Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cellsMei-Fway Iu, Hiroshi Kaji, Junko Naito, et al.
Endocrine Journal|June 26, 2002
Plasma lipids and osteoporosis in postmenopausal womenToru Yamaguchi, Toshitsugu Sugimoto, Shozo Yano, et al.
American Journal of Nephrology|August 10, 2002
Risk factors for hip fracture in hemodialysis patientsHiroshi Kaji, Mizune Suzuki, Shozo Yano, et al.
Endocrine Journal|September 27, 2006
Growth hormone (GH) effects on central fat accumulation in adult Japanese GH deficient patients: 6-month fixed-dose effects persist during second 6-month individualized-dose phaseKazuo Chihara, Akira Shimatsu, Yuzuru Kato, et al.
Endocrine Journal|September 2, 2006
Low-dose growth hormone treatment (0.175 mg/kg/week) for short stature in patients with Turner Syndrome: data from KIGS JapanYoshiya Ito, Kenji Fujieda, Toshiaki Tanaka, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Endocrine Journal|January 23, 2013
Efficacy, safety, and pharmacokinetics of sustained-release lanreotide (lanreotide Autogel) in Japanese patients with acromegaly or pituitary gigantismAkira Shimatsu, Akira Teramoto, Naomi Hizuka, et al.
JCEM Case Reports|May 20, 2026
Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenomaMaki Kanzawa, Takeshi Maeda, Yoshio Ohta, et al.
The Journal of Biological Chemistry|November 26, 2004
Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunDJunko Naito, Hiroshi Kaji, Hideaki Sowa, et al.
The Journal of Endocrinology|April 9, 2005
Dexamethasone suppresses Smad3 pathway in osteoblastic cellsMei-Fway Iu, Hiroshi Kaji, Hideaki Sowa, et al.
The Journal of Biological Chemistry|October 1, 2003
Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblastsHideaki Sowa, Hiroshi Kaji, Mei Fway Iu, et al.
Journal of Bone and Mineral Metabolism|November 2, 2005
Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cellsMei-Fway Iu, Hiroshi Kaji, Junko Naito, et al.
Endocrine Journal|June 26, 2002
Plasma lipids and osteoporosis in postmenopausal womenToru Yamaguchi, Toshitsugu Sugimoto, Shozo Yano, et al.
American Journal of Nephrology|August 10, 2002
Risk factors for hip fracture in hemodialysis patientsHiroshi Kaji, Mizune Suzuki, Shozo Yano, et al.
Endocrine Journal|September 27, 2006
Growth hormone (GH) effects on central fat accumulation in adult Japanese GH deficient patients: 6-month fixed-dose effects persist during second 6-month individualized-dose phaseKazuo Chihara, Akira Shimatsu, Yuzuru Kato, et al.
Endocrine Journal|September 2, 2006
Low-dose growth hormone treatment (0.175 mg/kg/week) for short stature in patients with Turner Syndrome: data from KIGS JapanYoshiya Ito, Kenji Fujieda, Toshiaki Tanaka, et al.
Pageof 15